WHO ICTRP trial
The ROAD to sustainable medication use: redispensing unused oral anticancer…
NL-OMON23519 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON23519 |
|---|---|
| Public title | The ROAD to sustainable medication use: redispensing unused oral anticancer drugs |
| Scientific title | Cost-savings and environmental impact obtained from redispensing unused oral anticancer drugs |
| Primary sponsor | Radboudumc |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | Oncology |
| Interventions | All participating patients will receive their prescribed oral anticancer drugs in the original manufacturer’s package supplemented with a validated time–temperature indicator (Elpro ITS temperature indicator, customer configuration)… |
| Registration date | Jan 28, 2021 |
| Target size | 1150 |
| Secondary IDs | NL9208;Commissie Mensgebonden Onderzoek Radboudumc : 2020-7049 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: